Description 464 amino acids; contains a phosphorylation site, an acidic domain, an HLH motif, and a leucine zipper in C-term; forms heterodimers with MAX and recognize the core concensus sequence CACCTG.
Protein
Description 464 amino acids; contains a phosphorylation site, an acidic domain, an HLH motif, and a leucine zipper in C-term; forms heterodimers with MAX and recognize the core concensus sequence CACCTG.
Expression
During fetal development.
Localisation
Nuclear.
Function
Probable transcription factor; possible role during tissue differentiation.
Homology
With members of the myc family of helix-loop-helix transcription factors.
MYCN (myc myelocytomatosis viral related oncogene, neuroblastoma derived)
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Mutations
Somatic
Amplification, either in extrachromosomal double minutes or in homogeneously staining regions within chromosomes (there is amplification when, for exemple, 10 to 1000 copies of a gene are present in a cell); found amplified in a variety of human tumours, in particular in and also in retinoblastoma, small cell lung carcinoma, astrocytoma; level of amplification related to the tumour progression; transgenic mice that overexpress MYCN in neuroectodermal cells develop neuroblastoma.
Implicated in
Neuroblastoma
Oncogenesis MYCN amplification is found in 15% of neuroblastoma, is an adverse prognostic feature per se, and is often associated with other adverse features (older age, abdominal tumour, advanced disease, and high lactate dehydrogenase, ferritin, and neuronspecific enolase serum levels).
